Mycophenolate Mofetil in the Treatment of Chronic Non-Infectious Uveitis

Principal Investigator

C. Michael Samson, M.D.

Enrollment Status

Objective

To determine if CellCept is as effective or more effective than Methotrexate in treating uveitis. This is a randomized, masked, controlled comparative trial against Methotrexate.

Conclusion

The data generates concordant evidence with other SUN-compliant studies supporting the use of Mycophenolate Mofetil in uveitis. For more information: ClinicalTrials.gov

Home > Current Research > Clinical Trials in Ophthalmology >Results > MYCOPHENOLATE MOFETIL IN THE TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS